He then licensed the discovery to Amylin Pharmaceuticals, which developed it into exenatide, marketed as Byetta
Screen-based detection of intracellular cAMP Islets were plated in clear-bottom 96-well plates with KRB containing 2.8 mmol/l glucose and stimulated for 20 min at 37C with KRB (20 mmol/l glucose) plus IBMX (500 mol/l), either alone or combined with forskolin (10 mol/l), GLP-1 (1 nmol/l) or triagonist (1 nmol/l)
One important note: early reports linked GLP-1 use to depression symptoms in a small number of patients, but large epidemiological studies have not confirmed this as a widespread concern
GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults With Obesity
In clinical trials, patients using semaglutide 2.4 mg weekly achieved average weight loss of 1215% of body weight over 68 weeks (approximately 26-33 lbs for a 220-lb person), substantially greater than placebo